| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypoxia | 11 | 2020 | 89 | 3.070 |
Why?
|
| Fetal Hypoxia | 11 | 2016 | 13 | 2.690 |
Why?
|
| Fetus | 15 | 2022 | 77 | 2.690 |
Why?
|
| Zika Virus | 5 | 2022 | 28 | 2.330 |
Why?
|
| Zika Virus Infection | 5 | 2022 | 28 | 2.320 |
Why?
|
| Sheep | 25 | 2020 | 100 | 2.300 |
Why?
|
| Corticotropin-Releasing Hormone | 13 | 2016 | 28 | 2.190 |
Why?
|
| Cervix Uteri | 4 | 2017 | 64 | 1.830 |
Why?
|
| Adipose Tissue | 7 | 2020 | 184 | 1.760 |
Why?
|
| Pituitary-Adrenal System | 9 | 2015 | 20 | 1.700 |
Why?
|
| Pregnancy | 28 | 2025 | 1181 | 1.700 |
Why?
|
| Hypothalamo-Hypophyseal System | 8 | 2015 | 19 | 1.600 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2022 | 47 | 1.560 |
Why?
|
| Hydrocortisone | 14 | 2017 | 89 | 1.500 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 6 | 2016 | 10 | 1.340 |
Why?
|
| Gene Expression Regulation | 6 | 2020 | 633 | 1.290 |
Why?
|
| Animals | 48 | 2025 | 10399 | 1.220 |
Why?
|
| Corticosterone | 8 | 2007 | 34 | 1.170 |
Why?
|
| Amygdala | 7 | 2007 | 51 | 1.120 |
Why?
|
| Altitude | 6 | 2015 | 14 | 1.090 |
Why?
|
| Interleukin-1beta | 3 | 2017 | 43 | 1.050 |
Why?
|
| Adrenal Cortex | 8 | 2017 | 13 | 1.020 |
Why?
|
| Leptin | 5 | 2017 | 67 | 1.020 |
Why?
|
| Pro-Opiomelanocortin | 7 | 2013 | 14 | 1.000 |
Why?
|
| Cervical Ripening | 2 | 2017 | 6 | 0.950 |
Why?
|
| Arginine Vasopressin | 4 | 2016 | 8 | 0.920 |
Why?
|
| Adrenocorticotropic Hormone | 7 | 2017 | 17 | 0.880 |
Why?
|
| Progesterone | 2 | 2017 | 129 | 0.880 |
Why?
|
| Female | 34 | 2025 | 15156 | 0.860 |
Why?
|
| Semen | 2 | 2020 | 29 | 0.820 |
Why?
|
| Obesity | 3 | 2022 | 668 | 0.740 |
Why?
|
| Adaptation, Physiological | 5 | 2015 | 169 | 0.740 |
Why?
|
| Behavior, Animal | 5 | 2017 | 107 | 0.730 |
Why?
|
| RNA, Messenger | 12 | 2014 | 656 | 0.720 |
Why?
|
| Nitric Oxide Synthase Type III | 5 | 2015 | 55 | 0.690 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 4 | 2005 | 12 | 0.690 |
Why?
|
| Dinoprostone | 2 | 2017 | 42 | 0.680 |
Why?
|
| Anxiety | 6 | 2017 | 146 | 0.680 |
Why?
|
| Monkey Diseases | 1 | 2020 | 16 | 0.670 |
Why?
|
| Vagina | 1 | 2020 | 42 | 0.660 |
Why?
|
| Adipose Tissue, Brown | 2 | 2020 | 14 | 0.640 |
Why?
|
| Pituitary Gland, Anterior | 6 | 2009 | 30 | 0.630 |
Why?
|
| Inflammation | 3 | 2025 | 626 | 0.610 |
Why?
|
| Papio anubis | 5 | 2025 | 48 | 0.610 |
Why?
|
| Gestational Age | 8 | 2015 | 141 | 0.610 |
Why?
|
| Diet | 2 | 2017 | 231 | 0.570 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 134 | 0.570 |
Why?
|
| Hyperphagia | 1 | 2017 | 6 | 0.570 |
Why?
|
| Receptors, Progesterone | 1 | 2017 | 17 | 0.560 |
Why?
|
| Misoprostol | 1 | 2017 | 2 | 0.560 |
Why?
|
| Alprostadil | 1 | 2017 | 4 | 0.560 |
Why?
|
| Adrenal Glands | 5 | 2013 | 21 | 0.560 |
Why?
|
| Oxytocics | 1 | 2017 | 5 | 0.550 |
Why?
|
| Labor, Induced | 1 | 2017 | 19 | 0.540 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2014 | 121 | 0.530 |
Why?
|
| Colon | 5 | 2005 | 120 | 0.530 |
Why?
|
| Fibroblasts | 1 | 2017 | 155 | 0.520 |
Why?
|
| Nitric Oxide | 3 | 2012 | 152 | 0.510 |
Why?
|
| Receptors, Leptin | 3 | 2013 | 6 | 0.500 |
Why?
|
| Memory Disorders | 1 | 2016 | 49 | 0.500 |
Why?
|
| Pituitary Gland | 4 | 1999 | 53 | 0.490 |
Why?
|
| Time Factors | 9 | 2015 | 1593 | 0.470 |
Why?
|
| Viremia | 3 | 2019 | 16 | 0.470 |
Why?
|
| Intra-Abdominal Fat | 1 | 2014 | 21 | 0.460 |
Why?
|
| Hippocampus | 1 | 2016 | 189 | 0.460 |
Why?
|
| Maze Learning | 5 | 2017 | 78 | 0.460 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2011 | 94 | 0.450 |
Why?
|
| Energy Metabolism | 1 | 2014 | 198 | 0.410 |
Why?
|
| Motor Activity | 3 | 2017 | 147 | 0.410 |
Why?
|
| Macrophage Activation | 1 | 2012 | 32 | 0.400 |
Why?
|
| Parturition | 1 | 2012 | 16 | 0.400 |
Why?
|
| Myeloid Cells | 1 | 2012 | 28 | 0.400 |
Why?
|
| Mitochondrial Proteins | 2 | 2014 | 72 | 0.390 |
Why?
|
| Male | 19 | 2025 | 13487 | 0.390 |
Why?
|
| Phosphoproteins | 3 | 2017 | 116 | 0.390 |
Why?
|
| 20-Hydroxysteroid Dehydrogenases | 1 | 2011 | 2 | 0.380 |
Why?
|
| Hydroxysteroid Dehydrogenases | 1 | 2011 | 3 | 0.380 |
Why?
|
| Disease Models, Animal | 7 | 2019 | 1461 | 0.380 |
Why?
|
| Rats | 10 | 2007 | 1564 | 0.370 |
Why?
|
| Mitochondria | 1 | 2014 | 366 | 0.370 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 2 | 2025 | 62 | 0.360 |
Why?
|
| Gene Expression | 3 | 2007 | 414 | 0.350 |
Why?
|
| Steroids | 1 | 2011 | 55 | 0.350 |
Why?
|
| Stress, Psychological | 4 | 2006 | 219 | 0.350 |
Why?
|
| Placenta | 2 | 2022 | 75 | 0.330 |
Why?
|
| Receptors, Glucocorticoid | 4 | 2013 | 18 | 0.320 |
Why?
|
| Fetal Blood | 1 | 2009 | 38 | 0.320 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2017 | 543 | 0.310 |
Why?
|
| Proprotein Convertases | 3 | 2022 | 11 | 0.290 |
Why?
|
| Ion Channels | 1 | 2008 | 24 | 0.290 |
Why?
|
| Abdominal Fat | 1 | 2008 | 17 | 0.290 |
Why?
|
| Adrenal Medulla | 1 | 2007 | 2 | 0.280 |
Why?
|
| Immunohistochemistry | 4 | 2016 | 462 | 0.270 |
Why?
|
| Biomarkers | 4 | 2025 | 755 | 0.270 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 2 | 2009 | 7 | 0.270 |
Why?
|
| Septal Nuclei | 1 | 2006 | 6 | 0.260 |
Why?
|
| In Situ Hybridization | 5 | 2006 | 34 | 0.260 |
Why?
|
| Testis | 2 | 2019 | 35 | 0.250 |
Why?
|
| Rats, Inbred F344 | 6 | 2007 | 170 | 0.250 |
Why?
|
| Uncoupling Protein 1 | 2 | 2020 | 14 | 0.250 |
Why?
|
| Receptors, Cell Surface | 1 | 2006 | 114 | 0.250 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 2005 | 11 | 0.240 |
Why?
|
| Fetal Weight | 3 | 2017 | 8 | 0.240 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2003 | 126 | 0.240 |
Why?
|
| Immunoglobulin G | 3 | 2022 | 270 | 0.240 |
Why?
|
| Pempidine | 1 | 2005 | 1 | 0.240 |
Why?
|
| Colitis | 1 | 2006 | 54 | 0.240 |
Why?
|
| Colonic Diseases | 1 | 2005 | 10 | 0.240 |
Why?
|
| Humans | 14 | 2023 | 28121 | 0.240 |
Why?
|
| Chronic Disease | 5 | 2015 | 273 | 0.240 |
Why?
|
| Diet, Western | 1 | 2025 | 28 | 0.240 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2005 | 32 | 0.230 |
Why?
|
| Hypothalamus | 3 | 2013 | 29 | 0.230 |
Why?
|
| Rats, Wistar | 4 | 2007 | 151 | 0.220 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2025 | 108 | 0.220 |
Why?
|
| Inflammation Mediators | 1 | 2025 | 165 | 0.220 |
Why?
|
| Intestinal Mucosa | 1 | 2025 | 197 | 0.220 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2025 | 103 | 0.200 |
Why?
|
| Subtilisins | 2 | 2022 | 6 | 0.200 |
Why?
|
| RNA, Viral | 2 | 2020 | 68 | 0.200 |
Why?
|
| Thermogenesis | 2 | 2014 | 19 | 0.190 |
Why?
|
| Antibodies, Viral | 2 | 2019 | 79 | 0.180 |
Why?
|
| Species Specificity | 2 | 2016 | 191 | 0.180 |
Why?
|
| Radioimmunoassay | 3 | 2007 | 45 | 0.180 |
Why?
|
| Bronchi | 1 | 2021 | 38 | 0.180 |
Why?
|
| Colonic Diseases, Functional | 1 | 2001 | 11 | 0.180 |
Why?
|
| Respiratory Mucosa | 1 | 2021 | 51 | 0.180 |
Why?
|
| Adult | 5 | 2017 | 7757 | 0.170 |
Why?
|
| Insulin Resistance | 1 | 2022 | 176 | 0.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2019 | 248 | 0.170 |
Why?
|
| Spermatozoa | 1 | 2019 | 33 | 0.160 |
Why?
|
| Transcriptome | 1 | 2020 | 214 | 0.160 |
Why?
|
| Microcephaly | 1 | 2019 | 8 | 0.160 |
Why?
|
| Immunity, Innate | 1 | 2021 | 225 | 0.160 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2019 | 13 | 0.150 |
Why?
|
| Fetal Death | 1 | 2019 | 21 | 0.150 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 1998 | 12 | 0.150 |
Why?
|
| Blotting, Western | 4 | 2013 | 510 | 0.150 |
Why?
|
| Fetal Diseases | 1 | 2019 | 18 | 0.150 |
Why?
|
| Acclimatization | 2 | 2009 | 30 | 0.150 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 451 | 0.150 |
Why?
|
| Cloning, Molecular | 1 | 1998 | 206 | 0.150 |
Why?
|
| Protein Isoforms | 1 | 1998 | 119 | 0.150 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 2017 | 5 | 0.140 |
Why?
|
| alpha-MSH | 1 | 2017 | 7 | 0.140 |
Why?
|
| Rats, Inbred WKY | 3 | 2007 | 13 | 0.140 |
Why?
|
| Weaning | 1 | 2017 | 18 | 0.140 |
Why?
|
| Promegestone | 1 | 2017 | 2 | 0.140 |
Why?
|
| Uterine Contraction | 1 | 2017 | 6 | 0.140 |
Why?
|
| Cells, Cultured | 3 | 2021 | 985 | 0.140 |
Why?
|
| Interleukin-8 | 1 | 2017 | 45 | 0.140 |
Why?
|
| Fear | 1 | 2017 | 60 | 0.140 |
Why?
|
| Animals, Newborn | 1 | 2017 | 180 | 0.130 |
Why?
|
| Water | 1 | 2017 | 135 | 0.130 |
Why?
|
| Feeding Behavior | 1 | 2017 | 102 | 0.130 |
Why?
|
| Spatial Memory | 1 | 2016 | 15 | 0.130 |
Why?
|
| Neural Stem Cells | 1 | 2016 | 13 | 0.130 |
Why?
|
| Pregnancy Outcome | 1 | 2017 | 131 | 0.130 |
Why?
|
| Neurogenesis | 1 | 2016 | 22 | 0.130 |
Why?
|
| Lipid Peroxidation | 1 | 2016 | 47 | 0.130 |
Why?
|
| Sheep, Domestic | 1 | 2016 | 6 | 0.130 |
Why?
|
| Interleukin-6 | 1 | 2017 | 193 | 0.130 |
Why?
|
| Pregnancy in Diabetics | 1 | 2015 | 21 | 0.120 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2015 | 36 | 0.120 |
Why?
|
| Pericardium | 1 | 2015 | 47 | 0.120 |
Why?
|
| Cholesterol | 3 | 2022 | 200 | 0.120 |
Why?
|
| Echocardiography | 1 | 2015 | 108 | 0.120 |
Why?
|
| Fetal Development | 1 | 2015 | 21 | 0.120 |
Why?
|
| Pyrroles | 2 | 2005 | 36 | 0.120 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 2014 | 4 | 0.120 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2014 | 19 | 0.120 |
Why?
|
| Ki-67 Antigen | 1 | 2014 | 23 | 0.120 |
Why?
|
| Electron Transport Complex IV | 1 | 2014 | 40 | 0.120 |
Why?
|
| Papio | 3 | 2023 | 79 | 0.110 |
Why?
|
| DNA, Mitochondrial | 1 | 2014 | 82 | 0.110 |
Why?
|
| Pyrimidines | 2 | 2005 | 126 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 156 | 0.110 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 157 | 0.110 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2014 | 121 | 0.110 |
Why?
|
| Muscle Contraction | 3 | 2005 | 170 | 0.100 |
Why?
|
| Models, Animal | 1 | 2014 | 128 | 0.100 |
Why?
|
| Autoradiography | 2 | 2006 | 28 | 0.100 |
Why?
|
| Brain | 1 | 2019 | 739 | 0.100 |
Why?
|
| Receptors, Corticotropin | 1 | 2013 | 2 | 0.100 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2013 | 3 | 0.100 |
Why?
|
| Steroid 21-Hydroxylase | 1 | 2013 | 7 | 0.100 |
Why?
|
| Fetal Growth Retardation | 1 | 2013 | 30 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 825 | 0.100 |
Why?
|
| Kidney | 1 | 2014 | 285 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 677 | 0.100 |
Why?
|
| Phenotype | 1 | 2014 | 679 | 0.100 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 95 | 0.100 |
Why?
|
| Drug Implants | 2 | 2003 | 14 | 0.100 |
Why?
|
| Rectum | 2 | 2003 | 50 | 0.090 |
Why?
|
| Cytokines | 2 | 2021 | 445 | 0.090 |
Why?
|
| Guanylate Cyclase | 1 | 2011 | 15 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2014 | 804 | 0.090 |
Why?
|
| Cyclic GMP | 1 | 2011 | 29 | 0.090 |
Why?
|
| Tyrosine | 1 | 2011 | 92 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 491 | 0.090 |
Why?
|
| Cysteine | 1 | 2011 | 68 | 0.090 |
Why?
|
| Ovary | 1 | 2011 | 69 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2014 | 522 | 0.090 |
Why?
|
| Enzyme Activation | 1 | 2011 | 267 | 0.090 |
Why?
|
| Heme | 1 | 2011 | 90 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2017 | 2380 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 102 | 0.090 |
Why?
|
| Epithelial Cells | 2 | 2023 | 247 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 326 | 0.080 |
Why?
|
| Receptors, Vasopressin | 1 | 2009 | 2 | 0.080 |
Why?
|
| Blotting, Northern | 2 | 1999 | 46 | 0.080 |
Why?
|
| Models, Biological | 1 | 2011 | 465 | 0.080 |
Why?
|
| Analysis of Variance | 2 | 2007 | 390 | 0.070 |
Why?
|
| Enzyme Inhibitors | 3 | 2017 | 249 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 1999 | 268 | 0.070 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2008 | 1 | 0.070 |
Why?
|
| Uncoupling Protein 2 | 1 | 2008 | 5 | 0.070 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2008 | 4 | 0.070 |
Why?
|
| Iodide Peroxidase | 1 | 2008 | 10 | 0.070 |
Why?
|
| PPAR gamma | 1 | 2008 | 29 | 0.070 |
Why?
|
| PPAR alpha | 1 | 2008 | 33 | 0.070 |
Why?
|
| Signal Transduction | 3 | 2021 | 1433 | 0.070 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2007 | 1 | 0.070 |
Why?
|
| Phenylethanolamine N-Methyltransferase | 1 | 2007 | 1 | 0.070 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2007 | 7 | 0.070 |
Why?
|
| Receptors, Muscarinic | 1 | 2007 | 9 | 0.070 |
Why?
|
| Receptors, Nicotinic | 1 | 2007 | 10 | 0.070 |
Why?
|
| Reflex | 2 | 2005 | 74 | 0.070 |
Why?
|
| Middle Aged | 2 | 2017 | 7164 | 0.070 |
Why?
|
| Catheterization | 2 | 2003 | 50 | 0.060 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2006 | 14 | 0.060 |
Why?
|
| Peroxidase | 1 | 2006 | 39 | 0.060 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2006 | 50 | 0.060 |
Why?
|
| Butadienes | 2 | 2017 | 14 | 0.060 |
Why?
|
| Hormone Antagonists | 1 | 2005 | 6 | 0.060 |
Why?
|
| Diagnostic Imaging | 1 | 2006 | 68 | 0.060 |
Why?
|
| Nitriles | 2 | 2017 | 33 | 0.060 |
Why?
|
| Physical Stimulation | 1 | 2005 | 72 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2005 | 78 | 0.060 |
Why?
|
| Cyclic AMP | 2 | 2010 | 86 | 0.060 |
Why?
|
| Stereotaxic Techniques | 1 | 2003 | 14 | 0.050 |
Why?
|
| Diffusion | 1 | 2003 | 39 | 0.050 |
Why?
|
| Thymus Gland | 1 | 2003 | 54 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2005 | 225 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2015 | 575 | 0.050 |
Why?
|
| Proprotein Convertase 9 | 1 | 2022 | 3 | 0.050 |
Why?
|
| Cholesterol, LDL | 1 | 2022 | 65 | 0.050 |
Why?
|
| Triglycerides | 1 | 2022 | 120 | 0.050 |
Why?
|
| Apoptosis | 1 | 2025 | 771 | 0.050 |
Why?
|
| Lipoproteins | 1 | 2022 | 99 | 0.050 |
Why?
|
| Instillation, Drug | 1 | 2001 | 7 | 0.050 |
Why?
|
| Interferons | 1 | 2021 | 69 | 0.040 |
Why?
|
| Cell Death | 1 | 2021 | 118 | 0.040 |
Why?
|
| Manometry | 1 | 2001 | 38 | 0.040 |
Why?
|
| Acetic Acid | 1 | 2001 | 28 | 0.040 |
Why?
|
| Spinal Cord | 1 | 2003 | 209 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2003 | 257 | 0.040 |
Why?
|
| Cellular Senescence | 1 | 2021 | 125 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2022 | 398 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2000 | 115 | 0.040 |
Why?
|
| Blood-Testis Barrier | 1 | 2019 | 3 | 0.040 |
Why?
|
| Lung | 1 | 2023 | 375 | 0.040 |
Why?
|
| Spermatogenesis | 1 | 2019 | 11 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 38 | 0.040 |
Why?
|
| Immunity, Humoral | 1 | 2019 | 47 | 0.040 |
Why?
|
| Proprotein Convertase 2 | 1 | 1998 | 1 | 0.040 |
Why?
|
| Alcoholism | 1 | 2000 | 120 | 0.040 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1998 | 8 | 0.040 |
Why?
|
| Stem Cells | 1 | 2019 | 122 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 1998 | 62 | 0.040 |
Why?
|
| Gene Library | 1 | 1998 | 45 | 0.040 |
Why?
|
| COS Cells | 1 | 1998 | 49 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2018 | 28 | 0.040 |
Why?
|
| Brazil | 1 | 2018 | 24 | 0.040 |
Why?
|
| Mucous Membrane | 1 | 2018 | 27 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 1998 | 111 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 1998 | 136 | 0.040 |
Why?
|
| Down-Regulation | 1 | 1998 | 198 | 0.040 |
Why?
|
| Transfection | 1 | 1998 | 318 | 0.040 |
Why?
|
| Binding Sites | 1 | 1998 | 354 | 0.040 |
Why?
|
| Substance-Related Disorders | 1 | 2000 | 185 | 0.030 |
Why?
|
| Base Sequence | 1 | 1998 | 584 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 689 | 0.030 |
Why?
|
| Macrophages | 1 | 2019 | 296 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 1998 | 1050 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2015 | 18 | 0.030 |
Why?
|
| Altitude Sickness | 1 | 2015 | 1 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 407 | 0.030 |
Why?
|
| Reference Values | 1 | 2015 | 200 | 0.030 |
Why?
|
| Hydroxycholesterols | 1 | 2015 | 7 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2015 | 8 | 0.030 |
Why?
|
| Acute Disease | 1 | 2015 | 158 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2015 | 123 | 0.030 |
Why?
|
| Aging | 1 | 2021 | 976 | 0.030 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 2013 | 2 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2013 | 23 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2013 | 22 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 968 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 330 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 5416 | 0.020 |
Why?
|
| Triazenes | 1 | 2010 | 2 | 0.020 |
Why?
|
| Nitroprusside | 1 | 2010 | 8 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2010 | 33 | 0.020 |
Why?
|
| Nitric Oxide Donors | 1 | 2010 | 11 | 0.020 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2010 | 31 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2009 | 15 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2009 | 40 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 112 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2015 | 2557 | 0.020 |
Why?
|
| Sensory Thresholds | 1 | 2003 | 14 | 0.010 |
Why?
|
| Sacrum | 1 | 2003 | 24 | 0.010 |
Why?
|
| Neurons, Afferent | 1 | 2003 | 64 | 0.010 |
Why?
|
| Lumbar Vertebrae | 1 | 2003 | 124 | 0.010 |
Why?
|
| Reflex, Startle | 1 | 2000 | 8 | 0.010 |
Why?
|
| Temperance | 1 | 2000 | 5 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 2000 | 30 | 0.010 |
Why?
|
| Saliva | 1 | 2000 | 96 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2000 | 255 | 0.010 |
Why?
|